FDA approves Pfizer for adolescents aged 12 to 15

Pfizer’s amended emergency use authorization (EUA) now states that the vaccines can be used for individuals aged 12 and above. Previously, the American-made jabs were allowed for the use of 16-year-olds and older.

Health Undersecretary Maria Rosario Vergeire noted, however, that the younger age group will not be vaccinated yet and the government will still follow the prioritization framework.

“While we welcome more vaccines that are approved for children and adolescents, due to limited vaccine supply, our vaccination strategy remains the same — prioritize the vulnerable and adhere to our prioritization framework,” Vergeire said.

She added that the vaccination of children and adolescents will be revisited once there is a stable supply of vaccines in the country.